about
RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody SpecificitiesA fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus.Drugs in early clinical development for Systemic Lupus Erythematosus.Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.Reduction of CD19 autoimmunity marker on B cells of paediatric SLE patients through repressing PU.1/TNF-α/BAFF axis pathway by miR-155.
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Novel treatments for systemic lupus erythematosus.
@ast
Novel treatments for systemic lupus erythematosus.
@en
type
label
Novel treatments for systemic lupus erythematosus.
@ast
Novel treatments for systemic lupus erythematosus.
@en
prefLabel
Novel treatments for systemic lupus erythematosus.
@ast
Novel treatments for systemic lupus erythematosus.
@en
P2860
P356
P1476
Novel treatments for systemic lupus erythematosus.
@en
P2093
Robert G Lahita
P2860
P304
P356
10.1177/1759720X11415456
P577
2011-10-01T00:00:00Z